Boehringer's first TV ad for Ofev leans on family ties by Beth Snyder Bulik Monday, February 25, 2019 In Boehringer Ingelheim’s first branded TV ad for its idiopathic pulmonary fibrosis treatment Ofev, the spotlight is not on the patient, but on a loved one.
How can new launches mimic Keytruda, Harvoni and Opdivo? by Eric Sagonowsky Thursday, November 16, 2017 In just a few years, pharma's top launches of 2014 have amassed huge sales and reshaped treatment—and they're now among the biggest launches ever.
Roche, Boehringer tout new IPF analyses to boost their meds by Carly Helfand Friday, May 26, 2017 This week, both IPF drugmakers upped the ante with positive new data for their contenders at the American Thoracic Society's annual meeting.
